XBIT

MKT CAP:$77M

XBiotech Inc.

Market Cap

$77M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$2.53+$0.15 (+6.30%)

Apr 23, 2026

Company Details

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammato...

CEO

Sushma Shivaswamy

IPO Date

Apr 15, 2015

Website

www.xbiotech.com

Key Metrics TTM

Revenue

$0

— YoY

Net Income

-$46M

EPS (Diluted)

-$1.50

Free Cash Flow

-$40M

Revenue / Share

$0.00

Gross Margin

—

Operating Margin

—

Net Margin

—

FCF Margin

—

P/S

—

P/E

—

Earnings Reports

Q1 2026

May 12, 2026

PENDING

FY 2025

Mar 13, 2026

$0EPS -$1.49

Q4 2025

Mar 13, 2026

$0EPS -$0.88

Q3 2025

Nov 12, 2025

$0EPS -$0.20

Q2 2025

Aug 13, 2025

$0EPS -$0.06

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$500.0K	$287.0K	-$8M
Q2 22	$2M	$1M	-$12M
Q3 22	$2M	$1M	-$6M
Q4 22	$300.0K	$284.0K	-$8M
Q1 23	$0	$0	-$7M
Q2 23	$0	$0	-$13M
Q3 23	$0	$0	-$9M
Q4 23	$0	-$434.0K	-$9M
Q1 24	$0	$0	-$11M
Q2 24	$0	$0	-$15M
Q3 24	$0	$0	-$8M
Q4 24	$0	$0	-$9M
Q1 25	$0	$0	-$14M
Q2 25	$0	$0	-$6M
Q3 25	$0	-$427.0K	-$6M
Q4 25	$0	-$378.0K	-$30M

Valuation

Quarter	P/S	P/E
Q1 22	19.6x	—
Q2 22	16.4x	—
Q3 22	13.2x	—
Q4 22	28.3x	—
Q1 23	30.0x	—
Q2 23	85.9x	—
Q3 23	390.6x	—
Q4 23	—	—
Q1 24	—	—
Q2 24	—	—
Q3 24	—	—
Q4 24	—	—
Q1 25	—	—
Q2 25	—	—
Q3 25	—	—
Q4 25	—	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	-$5M	-$5M
Q2 22	-$5M	-$5M
Q3 22	-$1M	-$1M
Q4 22	$3M	$3M
Q1 23	-$5M	-$5M
Q2 23	-$9M	-$9M
Q3 23	-$1M	-$2M
Q4 23	-$3M	-$4M
Q1 24	-$7M	-$7M
Q2 24	-$11M	-$12M
Q3 24	-$6M	-$6M
Q4 24	-$7M	-$7M
Q1 25	-$7M	-$7M
Q2 25	-$6M	-$6M
Q3 25	-$4M	-$4M
Q4 25	-$23M	-$23M

Capital Expenditures

Quarter	CapEx
Q1 22	$161.0K
Q2 22	$82.0K
Q3 22	$210.0K
Q4 22	$132.0K
Q1 23	$6.0K
Q2 23	$208.0K
Q3 23	$33.0K
Q4 23	$115.0K
Q1 24	$255.0K
Q2 24	$627.0K
Q3 24	$338.0K
Q4 24	$84.0K
Q1 25	$94.0K
Q2 25	$51.0K
Q3 25	$110.0K
Q4 25	$34.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	-89.7%	-0.7%
Q2 22	-66.2%	-10.0%
Q3 22	-62.8%	-2.2%
Q4 22	-93.3%	-27.6%
Q1 23	-100.0%	-14.4%
Q2 23	-100.0%	-2.7%
Q3 23	-100.0%	+5.6%
Q4 23	-100.0%	+1.5%
Q1 24	—	+51.9%
Q2 24	—	+12.9%
Q3 24	—	-7.2%
Q4 24	—	+1.9%
Q1 25	—	+24.9%
Q2 25	—	-57.7%
Q3 25	—	-23.5%
Q4 25	—	+240.1%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$1M	289.6%
Q2 22	$1M	94.6%
Q3 22	$1M	67.1%
Q4 22	$1M	346.0%
Q1 23	$705.0K	—
Q2 23	$914.0K	—
Q3 23	$955.0K	—
Q4 23	$688.0K	—
Q1 24	$381.0K	—
Q2 24	$379.0K	—
Q3 24	$365.0K	—
Q4 24	$628.0K	—
Q1 25	$3M	—
Q2 25	$107.0K	—
Q3 25	$24.0K	—
Q4 25	$0	—

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q1 22	$7M	$1M	—
Q2 22	$10M	$3M	—
Q3 22	$7M	$840.0K	—
Q4 22	$7M	$1M	—
Q1 23	$6M	$915.0K	—
Q2 23	$11M	$2M	—
Q3 23	$8M	$973.0K	—
Q4 23	$8M	—	$349.0K
Q1 24	$10M	$1M	—
Q2 24	$13M	$2M	—
Q3 24	$7M	$777.0K	—
Q4 24	$8M	$927.0K	—
Q1 25	$12M	$2M	—
Q2 25	$5M	$1M	—
Q3 25	$5M	—	$540.0K
Q4 25	$25M	—	$4M

Revenue Segments

Quarter	Manufacturing Revenue
Q1 22	$500.0K
Q2 22	$2M
Q3 22	$2M
Q4 22	$300.0K

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$232M	$0	$232M
Q2 22	$226M	$0	$226M
Q3 22	$161M	$60M	$220M
Q4 22	$157M	$60M	$217M
Q1 23	$152M	$60M	$213M
Q2 23	$143M	$61M	$205M
Q3 23	$202M	$0	$202M
Q4 23	$200M	$0	$200M
Q1 24	$201M	$0	$201M
Q2 24	$189M	$0	$189M
Q3 24	$183M	$0	$183M
Q4 24	$173M	$0	$173M
Q1 25	$156M	$0	$156M
Q2 25	$153M	$0	$153M
Q3 25	$147M	$0	$147M
Q4 25	$126M	$0	$126M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	30M	-1.0%	+2.1%
Q2 22	30M	+1.3%	+1.5%
Q3 22	30M	0.0%	+0.3%
Q4 22	30M	-0.0%	+0.3%
Q1 23	30M	0.0%	+1.3%
Q2 23	30M	-0.0%	-0.0%
Q3 23	30M	-0.0%	-0.0%
Q4 23	30M	+0.0%	-0.0%
Q1 24	30M	+0.0%	+0.0%
Q2 24	30M	+0.0%	+0.1%
Q3 24	30M	+0.1%	+0.1%
Q4 24	30M	-0.0%	+0.1%
Q1 25	30M	+0.1%	+0.1%
Q2 25	30M	0.0%	+0.1%
Q3 25	30M	0.0%	+0.0%
Q4 25	30M	0.0%	+0.1%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 22	$5.2K	97
Q2 22	$15.8K	97
Q3 22	$17.3K	97
Q4 22	$3.5K	85
Q1 23	$0	85
Q2 23	$0	85
Q3 23	$0	85
Q4 23	$0	82
Q1 24	$0	82
Q2 24	$0	82
Q3 24	$0	82
Q4 24	$0	92
Q1 25	$0	92
Q2 25	$0	92
Q3 25	$0	92
Q4 25	$0	85

Revenue / Employee